Streetbeat News

Products Services

TPST

Tempest Therapeutics Inc (NASDAQ:TPST) released new results from an ongoing Phase 1b/2 study of TPST-1120 in the treatment of patients with unresectable or metastatic hepatocellular carcinoma (HCC). The study shows TPST-1120's clinical superiority in multiple endpoints when combined with atezolizumab and bevacizumab. The confirmed objective response rate was 30% for the TPST-1120 arm versus 13.3% for the control arm. The progression-free survival was a median of 7 months for the TPST-1120 arm versus 4.27 months for the control arm. TPST shares are up 800.40% at $2.16 during the premarket session on the last check Wednesday.

Portfolio Pulse from Vandana Singh

October 11, 2023 | 1:24 pm

VJET

Voxeljet (NASDAQ:VJET) has been selected by GE Research for a $14.9M contract funded by the U.S. Department of Energy (DoE) to develop advanced manufacturing technologies. The project aims to develop a voxeljet sand binder jet 3D printer for manufacturing large sand-casting molds, which will be used to produce metallic near net shape (NNS) components for the wind and hydro energy sectors. The goal is to reduce production time and costs, with the potential to reduce overall hydropower costs by 20% and lead times by four months.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:16 pm

ANAB

AnaptysBio is set to present Phase 1 data on ANB032, its BTLA agonist antibody, at the 32nd EADV Congress. This could potentially impact the company's stock performance.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:16 pm

TPST

Tempest Therapeutics has released new data showing the superiority of TPST-1120 arm across multiple study endpoints in a first-line hepatocellular carcinoma study. This has led to a rise in the company's share prices.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:13 pm

BCT

BCTX

BCTXW

BriaCell Therapeutics Corp. (NASDAQ:BCTX, BCTXW) (TSX:BCT) will host a virtual Key Opinion Leader (KOL) event on October 26, 2023, to discuss the potential of Bria-IMT™ in advanced metastatic breast cancer. The event will feature Dr. Adam M. Brufsky from the University of Pittsburgh School of Medicine and Dr. Saranya Chumsri from Mayo Clinic. BriaCell recently reported patient survival and clinical benefit with median overall survival of 13.5 months in BriaCell's advanced metastatic breast cancer patients. Bria-IMT™ has been awarded Fast Track status by the U.S Food and Drug Administration for the treatment of advanced metastatic breast cancer and initiated a phase 3 pivotal registration study.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:11 pm

AAPL

Apple Inc.'s 13-inch MacBook Air, powered by the M1 chipset, is now available at a $330 discount on Woot. The deal applies to the 16GB RAM and 256GB SSD configuration in the Space Gray color option.

Portfolio Pulse from Rounak Jain

October 11, 2023 | 1:10 pm

IOT

Samsara Inc. (NYSE:IOT) has announced its growth in the U.S. public sector, with the City of Houston being the latest to digitize its operations using Samsara's Connected Operations Cloud. The company's platform is being used to increase service transparency, sustainability, and safety, and to take data-informed actions. Other customers include the State of New Jersey, City of Fresno, and Hernando County. Samsara's recent fiscal quarter results showed that two of its top-five new customers and two of its top-five expansion deals were within the public sector.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:07 pm

AI

SHEL

C3 AI (NYSE:AI) and Shell Global Solutions International BV are expanding their collaboration to include Shell's predictive maintenance software in the C3 AI Reliability application. The software, developed by Shell, anticipates maintenance needs for control valves and critical equipment. The integration will make the technology available to other customers and further advance C3 AI Reliability as the industry standard for predictive maintenance. The collaboration is part of a roadmap focusing on safety, asset integrity, process and production optimization, and sustainability solutions.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:07 pm

ROKU

Roku Inc has entered into a multi-title international distribution partnership with Fifth Season. Under the agreement, Fifth Season will serve as Roku's international format and tape distribution partner for an initial slate of unscripted Roku Originals.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:07 pm

VTEX

VTEX, a digital commerce platform, has delivered cost savings of $5.8 million to enterprise merchants that migrated from legacy commerce platforms. The return on investment was 133%. The platform also provided savings in developer and platform support efficiency, ranging from 20% in the first year to 50% in the third year. Additionally, ecommerce business growth yielded an extra $17.1 million.

Portfolio Pulse from Benzinga Newsdesk

October 11, 2023 | 1:05 pm